Titan Pharmaceuticals (TTNP) Reports Q4 Loss of $0.26

Titan Pharmaceuticals, Inc. (: TTNP) reported Q4 EPS of ($0.26), versus ($0.09) reported last year. Revenue for the quarter came in at $1.41 million, versus $2.73 million reported last year.

For earnings history and earnings-related data on Titan Pharmaceuticals, Inc. (TTNP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c